Molecular pathology of the CFTR locus in male infertility

被引:100
作者
Claustres, M [1 ]
机构
[1] CHU Montpellier, Inst Univ Rech Clin, Lab Genet Mol & Chromosom, F-34093 Montpellier 5, France
关键词
alternative splicing; congenital bilateral absence of vas deferens; cystic fibrosis transmembrane conductance; regulator; polyvariant mutant genes; variable penetrance;
D O I
10.1016/S1472-6483(10)60801-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Congenital bilateral absence of the vas deferens (CBAVD) is a form of infertility with an autosomal recessive genetic background in otherwise healthy males. CBAVD is caused by cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations on both alleles in approximately 80% of cases. Striking CFTR genotypic differences are observed in cystic fibrosis (CF) and in CBAVD. The 5T allele is a CBAVD mutation with incomplete penetrance. Recent evidence confirmed that a second polymorphic locus exists and is a major CFTR modifier. The development of minigene models have led to results suggesting that CFTR exon 9 is skipped in humans because of unusual suboptimal 5' splice sites. An extremely rare T3 allele has been reported and it has recently been confirmed that the T3 allele dramatically increases exon 9 skipping and should be considered as a 'CF' mutation. Routine testing for the most prevalent mutations in the CF Caucasian population will miss most CFTR gene alterations, which can be detected only through exhaustive scanning of CFTR sequences. Finally, a higher than expected frequency of CFTR mutations and/or polymorphisms is now found in a growing number of monosymptomatic disorders, which creates a dilemma for setting nosologic boundaries between CF and diseases related to CFTR.
引用
收藏
页码:14 / 41
页数:28
相关论文
共 199 条
[51]   Pancreatitis and mutations of the cystic fibrosis gene [J].
Durie, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (10) :687-688
[52]   DIAGNOSTIC-CRITERIA FOR CYSTIC-FIBROSIS IN MEN WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
DURIEU, I ;
BEYOMAR, F ;
ROLLET, J ;
CALEMARD, L ;
BOGGIO, D ;
LEJEUNE, H ;
GILLY, R ;
MOREL, Y ;
DURAND, DV .
MEDICINE, 1995, 74 (01) :42-47
[53]   Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes [J].
Ellsworth, RE ;
Jamison, DC ;
Touchman, JW ;
Chissoe, SL ;
Maduro, VVB ;
Bouffard, GG ;
Dietrich, NL ;
Beckstrom-Sternberg, SM ;
Iyer, LM ;
Weintraub, LA ;
Cotton, M ;
Courtney, L ;
Edwards, J ;
Maupin, R ;
Ozersky, P ;
Rohlfing, T ;
Wohldmann, P ;
Miner, T ;
Kemp, K ;
Kramer, J ;
Korf, I ;
Pepin, K ;
Antonacci-Fulton, L ;
Fulton, RS ;
Minx, P ;
Hillier, LW ;
Wilson, RK ;
Waterston, RH ;
Miller, W ;
Green, ED .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1172-1177
[54]   Complexity in a monogenic disease [J].
Estivill, X .
NATURE GENETICS, 1996, 12 (04) :348-350
[55]  
Evans JP, 2002, NAT MED, V8, P57
[56]   Pre-mRNA splicing and human disease [J].
Faustino, NA ;
Cooper, TA .
GENES & DEVELOPMENT, 2003, 17 (04) :419-437
[57]   Homozygosity of the cystic fibrosis (CF) gene allele IVS8-(5T) in a Tamil male with congenital bilateral absence of the vas deferens (CBAVD) [J].
Fokstuen, S ;
Balakrishnan, J ;
Kotzot, D ;
Hergersberg, M ;
Hobi, C .
MOLECULAR HUMAN REPRODUCTION, 2000, 6 (07) :669-670
[58]  
Friedman KJ, 1997, HUM MUTAT, V10, P108, DOI 10.1002/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.0.CO
[59]  
2-G
[60]   2 CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MUTATIONS HAVE DIFFERENT EFFECTS ON BOTH PULMONARY PHENOTYPE AND REGULATION OF OUTWARDLY RECTIFIED CHLORIDE CURRENTS [J].
FULMER, SB ;
SCHWIEBERT, EM ;
MORALES, MM ;
GUGGINO, WB ;
CUTTING, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6832-6836